A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain
Global Assessment of Treatment With IONSYS and Its Handling by Patients, Doctors and Nursing Staff in the Management of Acute Moderate to Severe Post-Surgery Pain in Hospitalised Patients
Sponsor: Janssen-Cilag G.m.b.H
Terminated
The study was prematurely discontinued since study medication was no longer available.
Other terminated trials from Janssen-Cilag G.m.b.H
Listed as NCT01804673, this PHASE4 trial focuses on Postoperative Pain and remains terminated or withdrawn. Sponsored by Janssen-Cilag G.m.b.H, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen-Cilag G.m.b.H
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Augsburg, Germany , Berlin, Germany , Bremen, Germany , Cologne, Germany , Detmold, Germany , Dresden, Germany , Erfurt, Germany , Erlangen, Germany , Frankfurt, Germany , Halle, Germany and 12 more locations